Literature DB >> 9053839

In bone marrow derived Baf-3 cells, inhibition of apoptosis by IL-3 is mediated by two independent pathways.

Y Leverrier1, J Thomas, G R Perkins, M Mangeney, M K Collins, J Marvel.   

Abstract

The inhibition of cell death by growth factors plays a key role in the maintenance of the haematopoietic system homeostasis. However the mechanisms involved in this inhibition are still poorly understood. In order to determine if inhibition of apoptosis by growth factors is dependent only on the expression of survival genes, we have studied that process in the bone marrow derived IL-3 dependent cell line Baf-3. We show that, following IL-3 starvation, mRNA and protein levels of Bcl-X but not Bcl-2 decrease rapidly preceeding the onset of death. The death of IL-3 starved cells is asynchronous, starting between 6 to 8 h with 50% death being reached after 10 to 12 h. At any time point, apoptosis can be rapidly inhibited by growth factor re-addition. This has allowed us to determine that the inhibition of apoptosis by growth factor takes place at two levels. The first one, which we have called short term inhibition, is independent of mRNA and protein synthesis i.e. it takes place in the absence of survival gene neosynthesis and can be demonstrated during the first 6 h following growth factor re-addition. The second one corresponds to long-term survival-more than 24 h survival-and is strongly correlated with the induction of Bcl-X but not Bcl-2 gene expression. This induction of Bcl-X by IL-3 is shown to be dependent on MAP-kinase activation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9053839     DOI: 10.1038/sj.onc.1200845

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

Review 1.  Cytokine-mediated cell survival.

Authors:  Toshiya Inaba
Journal:  Int J Hematol       Date:  2004-10       Impact factor: 2.490

Review 2.  Histopathological evaluation of apoptosis in cancer.

Authors:  Y Soini; P Pääkkö; V P Lehto
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

3.  Downregulation of Bim, a proapoptotic relative of Bcl-2, is a pivotal step in cytokine-initiated survival signaling in murine hematopoietic progenitors.

Authors:  T Shinjyo; R Kuribara; T Inukai; H Hosoi; T Kinoshita; A Miyajima; P J Houghton; A T Look; K Ozawa; T Inaba
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

4.  CREB is one component of the binding complex of the Ces-2/E2A-HLF binding element and is an integral part of the interleukin-3 survival signal.

Authors:  W Chen; Y L Yu; S F Lee; Y J Chiang; J R Chao; J H Huang; J H Chiong; C J Huang; M Z Lai; H F Yang-Yen; J J Yen
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

5.  Coupling of osteopontin and its cell surface receptor CD44 to the cell survival response elicited by interleukin-3 or granulocyte-macrophage colony-stimulating factor.

Authors:  Y H Lin; C J Huang; J R Chao; S T Chen; S F Lee; J J Yen; H F Yang-Yen
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

6.  Two distinct interleukin-3-mediated signal pathways, Ras-NFIL3 (E4BP4) and Bcl-xL, regulate the survival of murine pro-B lymphocytes.

Authors:  R Kuribara; T Kinoshita; A Miyajima; T Shinjyo; T Yoshihara; T Inukai; K Ozawa; A T Look; T Inaba
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

7.  Two distinct signaling pathways downstream of Janus kinase 2 play redundant roles for antiapoptotic activity of granulocyte-macrophage colony-stimulating factor.

Authors:  R Liu; T Itoh; K I Arai; S Watanabe
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

8.  Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies.

Authors:  G Packham; E L White; C M Eischen; H Yang; E Parganas; J N Ihle; D A Grillot; G P Zambetti; G Nuñez; J L Cleveland
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

9.  Roles of Bim in apoptosis of normal and Bcr-Abl-expressing hematopoietic progenitors.

Authors:  Ryoko Kuribara; Hiroaki Honda; Hirotaka Matsui; Tetsuharu Shinjyo; Takeshi Inukai; Kanji Sugita; Shinpei Nakazawa; Hisamaru Hirai; Keiya Ozawa; Toshiya Inaba
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

10.  Overexpression of transcription factor Sp1 leads to gene expression perturbations and cell cycle inhibition.

Authors:  Emmanuelle Deniaud; Joël Baguet; Roxane Chalard; Bariza Blanquier; Lilia Brinza; Julien Meunier; Marie-Cécile Michallet; Aurélie Laugraud; Claudette Ah-Soon; Anne Wierinckx; Marc Castellazzi; Joël Lachuer; Christian Gautier; Jacqueline Marvel; Yann Leverrier
Journal:  PLoS One       Date:  2009-09-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.